Browsing byAuthorOakes, SR

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 7 to 13 of 13< previous 
Issue DateTitleAuthor(s)
2007-01-25Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesionsOakes, SR; Robertson, FG; Kench, JG; Gardiner-Garden, M; Wand, MP; Green, JE; Ormandy, CJ
2020-02MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma.Castillo, L; Young, AIJ; Mawson, A; Schafranek, P; Steinmann, AM; Nessem, D; Parkin, A; Johns, A; Chou, A; Law, AMK; Lucas, MC; Murphy, KJ; Deng, N; Gallego-Ortega, D; Caldon, CE; Australian Pancreatic Cancer Genome Initiative (APGI); Timpson, P; Pajic, M; Ormandy, CJ; Oakes, SR
2016-12-08MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.Young, AIJ; Law, AMK; Castillo, L; Chong, S; Cullen, HD; Koehler, M; Herzog, S; Brummer, T; Lee, EF; Fairlie, WD; Lucas, MC; Herrmann, D; Allam, A; Timpson, P; Watkins, DN; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR
2018Myeloid cell leukemia 1 (MCL-1), an unexpected modulator of protein kinase signaling during invasion.Young, AI; Timpson, P; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR
2018Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology.Valdes-Mora, F; Handler, K; Law, AMK; Salomon, R; Oakes, SR; Ormandy, CJ; Gallego-Ortega, D
2021-04-13Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype.Valdés-Mora, F; Salomon, R; Gloss, BS; Law, AMK; Venhuizen, J; Castillo, L; Murphy, KJ; Magenau, A; Papanicolaou, M; Rodriguez de la Fuente, L; Roden, DL; Colino-Sanguino, Y; Kikhtyak, Z; Farbehi, N; Conway, JRW; Sikta, N; Oakes, SR; Cox, TR; O'Donoghue, SI; Timpson, P; Ormandy, CJ; Gallego-Ortega, D
2014-11The mammary cellular hierarchy and breast cancer.Oakes, SR; Gallego-Ortega, D; Ormandy, CJ